Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 113617-63-3
2. Orbax
3. Nsc-758614
4. 660932tpy6
5. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid
6. 3-quinolinecarboxylic Acid, 1-cyclopropyl-7-[(3r,5s)-3,5-dimethyl-1-piperazinyl]-5,6,8-trifluoro-1,4-dihydro-4-oxo-, Rel-
7. Ncgc00160518-01
8. Dsstox_cid_26201
9. Dsstox_rid_81432
10. Dsstox_gsid_46201
11. 1-cyclopropyl-7-((3s,5r)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
12. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylic Acid
13. Smr000544203
14. Cp-104354
15. Orbifloxacin [inn]
16. Cas-113617-63-3
17. Sr-01000790054
18. Orbifloxacin [usp:inn:ban]
19. Mfcd00864858
20. Unii-660932tpy6
21. 1-cyclopropyl-7-((3r,5s)-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
22. Specplus_000366
23. Cp 104354
24. Orbifloxacin (usp/inn)
25. Orbifloxacin [mi]
26. Orbax [veterinary] (tn)
27. Orbifloxacin [jan]
28. Orbifloxacin Impurity Mixture
29. Orbifloxacin [mart.]
30. Mls000766847
31. Mls001216436
32. Divk1c_006462
33. Orbifloxacin [usp-rs]
34. Schembl125116
35. Chembl295433
36. Dtxsid7046201
37. Kbio1_001406
38. Orbifloxacin [green Book]
39. Chebi:183823
40. Hms2875g03
41. Hms3264m13
42. Pharmakon1600-01503711
43. Orbifloxacin [usp Impurity]
44. Bcp18829
45. Hy-b0915
46. Rkl10078
47. Zinc3882891
48. Orbifloxacin [usp Monograph]
49. Tox21_111867
50. Nsc758614
51. S4150
52. Akos015969739
53. Tox21_111867_1
54. Ccg-213832
55. Cs-4384
56. Db11443
57. Ks-5013
58. Nsc 758614
59. Orbifloxacin 100 Microg/ml In Methanol
60. Ncgc00160518-02
61. Ncgc00160518-03
62. Ncgc00160518-04
63. 1-cyclopropyl-5,6,8-trifluoro-1,4-dihydro-7-(cis-3,5-dimethyl-1-piperazinyl)-4-oxo-quinoline-3-carboxylic Acid
64. Sbi-0207085.p001
65. Orbifloxacin 100 Microg/ml In Acetonitrile
66. O0516
67. D08299
68. D91881
69. O-2950
70. Ab00833179_04
71. Ab00833179_05
72. Orbifloxacin, Vetranal(tm), Analytical Standard
73. A803076
74. Orbifloxacin, Antibiotic For Culture Media Use Only
75. Q7100015
76. Sr-01000790054-2
77. Sr-01000790054-3
78. Brd-k63001556-001-03-9
79. Orbifloxacin, European Pharmacopoeia (ep) Reference Standard
80. Orbifloxacin, United States Pharmacopeia (usp) Reference Standard
81. 1-cyclopropyl-5,6,8-trifluoro-7-(cis-3,5-dimethyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
82. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid
83. 1-cyclopropyl-7-(cis-3,5-dimethyl-1-piperazinyl)-5,6,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic Acid
84. 1-cyclopropyl-7-(cis-3,5-dimethylpiperazin-1-yl)-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid
85. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-quinoline-3-carboxylic Acid
86. 1-cyclopropyl-7-[(3r,5s)-3,5-dimethylpiperazin-4-ium-1-yl]-5,6,8-trifluoro-4-oxoquinoline-3-carboxylate
87. 1-cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-triluoro-4-oxoquinoline-3-carboxylic Acid
Molecular Weight | 395.4 g/mol |
---|---|
Molecular Formula | C19H20F3N3O3 |
XLogP3 | 0.9 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Exact Mass | 395.14567599 g/mol |
Monoisotopic Mass | 395.14567599 g/mol |
Topological Polar Surface Area | 72.9 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 691 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
25
PharmaCompass offers a list of Orbifloxacin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Orbifloxacin manufacturer or Orbifloxacin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Orbifloxacin manufacturer or Orbifloxacin supplier.
PharmaCompass also assists you with knowing the Orbifloxacin API Price utilized in the formulation of products. Orbifloxacin API Price is not always fixed or binding as the Orbifloxacin Price is obtained through a variety of data sources. The Orbifloxacin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Orbax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Orbax, including repackagers and relabelers. The FDA regulates Orbax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Orbax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Orbax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Orbax supplier is an individual or a company that provides Orbax active pharmaceutical ingredient (API) or Orbax finished formulations upon request. The Orbax suppliers may include Orbax API manufacturers, exporters, distributors and traders.
click here to find a list of Orbax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Orbax DMF (Drug Master File) is a document detailing the whole manufacturing process of Orbax active pharmaceutical ingredient (API) in detail. Different forms of Orbax DMFs exist exist since differing nations have different regulations, such as Orbax USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Orbax DMF submitted to regulatory agencies in the US is known as a USDMF. Orbax USDMF includes data on Orbax's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Orbax USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Orbax suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Orbax as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Orbax API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Orbax as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Orbax and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Orbax NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Orbax suppliers with NDC on PharmaCompass.
Orbax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Orbax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Orbax GMP manufacturer or Orbax GMP API supplier for your needs.
A Orbax CoA (Certificate of Analysis) is a formal document that attests to Orbax's compliance with Orbax specifications and serves as a tool for batch-level quality control.
Orbax CoA mostly includes findings from lab analyses of a specific batch. For each Orbax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Orbax may be tested according to a variety of international standards, such as European Pharmacopoeia (Orbax EP), Orbax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Orbax USP).